DB
GLMD icon

Dmitry Balyasny’s Galmed Pharmaceuticals GLMD Stock Holding History

Dmitry Balyasny’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-88
Closed -$1.51M – 1804
2018
Q2 		$1.51M Buy
+88
New +$1.02M 0.01% 1025

Other funds holding GLMD

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dmitry Balyasny's GLMD Position: Q3 2018 in Review

Dmitry Balyasny sold out of Galmed Pharmaceuticals (GLMD) in Q3 2018, closing a stake of 88 shares — an estimated $1.51M sold.

Dmitry Balyasny first reported a position in GLMD in Q2 2018 and held it in 1 quarter. The position peaked at $1.51M in Q2 2018. 30 funds tracked by Wall St. Rank hold GLMD as of Q3 2018.

  • Dmitry Balyasny reported no remaining Galmed Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Dmitry Balyasny sold 88 Galmed Pharmaceuticals shares in Q3 2018, an estimated $1.51M.
  • Dmitry Balyasny first reported a position in Galmed Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Dmitry Balyasny's Galmed Pharmaceuticals position peaked at $1.51M in Q2 2018.
  • 30 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q3 2018.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.